Dapsone treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome.
All patients with the acquired immunodeficiency syndrome treated for their first episode of Pneumocystis carinii pneumonia at San Francisco General Hospital between 1 April 1985 and 15 July 1985 were evaluated for their response to treatment with dapsone (100 mg/day) by mouth for 21 days. Of 44 pati...
Gardado en:
| Publicado en: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Society for Microbiology (ASM)
1988
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172343/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3263834/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.32.7.1057 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
